Data as of Aug 20
| +0.01 / +0.12%|
The 3 analysts offering 12-month price forecasts for Accretive Health Inc have a median target of 10.00, with a high estimate of 14.00 and a low estimate of 7.00. The median estimate represents a +21.80% increase from the last price of 8.21.
The current consensus among 3 polled investment analysts is to Buy stock in Accretive Health Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.